Cargando…
Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287437/ http://dx.doi.org/10.1186/1897-4287-10-S1-A4 |
| _version_ | 1782224662910992384 |
|---|---|
| author | Byrski, T Huzarski, T Marczyk, E Blecharz, P Gronwald, J Ashuryk, O Cybulski, C Dębniak, T Zuziak, D Godlewski, D Kladny, J Lubinski, J Narod, SA |
| author_facet | Byrski, T Huzarski, T Marczyk, E Blecharz, P Gronwald, J Ashuryk, O Cybulski, C Dębniak, T Zuziak, D Godlewski, D Kladny, J Lubinski, J Narod, SA |
| author_sort | Byrski, T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3287437 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32874372012-02-28 Why choose the treatment with cisplatin for BRCA1 breast cancers patients? Byrski, T Huzarski, T Marczyk, E Blecharz, P Gronwald, J Ashuryk, O Cybulski, C Dębniak, T Zuziak, D Godlewski, D Kladny, J Lubinski, J Narod, SA Hered Cancer Clin Pract Meeting Abstract BioMed Central 2012-01-12 /pmc/articles/PMC3287437/ http://dx.doi.org/10.1186/1897-4287-10-S1-A4 Text en Copyright ©2012 Byrski et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Meeting Abstract Byrski, T Huzarski, T Marczyk, E Blecharz, P Gronwald, J Ashuryk, O Cybulski, C Dębniak, T Zuziak, D Godlewski, D Kladny, J Lubinski, J Narod, SA Why choose the treatment with cisplatin for BRCA1 breast cancers patients? |
| title | Why choose the treatment with cisplatin for BRCA1 breast cancers patients? |
| title_full | Why choose the treatment with cisplatin for BRCA1 breast cancers patients? |
| title_fullStr | Why choose the treatment with cisplatin for BRCA1 breast cancers patients? |
| title_full_unstemmed | Why choose the treatment with cisplatin for BRCA1 breast cancers patients? |
| title_short | Why choose the treatment with cisplatin for BRCA1 breast cancers patients? |
| title_sort | why choose the treatment with cisplatin for brca1 breast cancers patients? |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287437/ http://dx.doi.org/10.1186/1897-4287-10-S1-A4 |
| work_keys_str_mv | AT byrskit whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT huzarskit whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT marczyke whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT blecharzp whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT gronwaldj whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT ashuryko whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT cybulskic whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT debniakt whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT zuziakd whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT godlewskid whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT kladnyj whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT lubinskij whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients AT narodsa whychoosethetreatmentwithcisplatinforbrca1breastcancerspatients |